Post-laser hyperpigmentation: prevention and treatment

Post-laser hyperpigmentation is a darkening of the skin that can follow laser and other energy-based treatments, a form of post-inflammatory hyperpigmentation (PIH). It appears as tan, brown, or gray-brown patches in the treated area, usually within days to weeks, and is more common in people with richer skin tones [1][3]. Although it is one of the more common complications of pigment and resurfacing lasers, it is typically temporary and treatable, and much of the risk can be lowered before the procedure ever happens [2][3].

This article explains why energy-based devices can trigger hyperpigmentation, who is most at risk, and what the evidence supports for preventing and treating it. It is not medical advice; diagnosis and treatment should be directed by a board-certified dermatologist.

What post-laser hyperpigmentation is

PIH is an acquired increase in pigment that develops after skin inflammation or injury, including the controlled injury of a cosmetic procedure [3]. When a laser, intense pulsed light, or radiofrequency device delivers energy to the skin, the resulting heat and inflammation can stimulate pigment-producing cells to deposit extra melanin in the treated area [2][3]. The result is a flat patch that is darker than the surrounding skin. It differs from the redness and temporary darkening that are expected in the first days after many procedures; true PIH persists for weeks to months [1].

Unlike melasma, which tends to recur and is difficult to clear, PIH can resolve on its own over time and can be cleared in most cases with treatment [4]. The timeline varies from person to person and depends on how deep the pigment sits.

Why it happens and who is most at risk

The central risk factor is skin tone. PIH disproportionately affects people with skin of color, Fitzpatrick types III to VI, because more active pigment cells respond more readily to inflammation [3]. Anything that increases inflammation or heat in the skin can raise the risk, including aggressive device settings, treatment of a tanned or sun-exposed area, and certain wavelengths [1][2].

A systematic review of hyperpigmentation after carbon dioxide laser found that PIH incidence varied widely between studies and appeared to depend more on how the treatment was performed than on Fitzpatrick type alone, with post-procedure inflammation seeming to drive the risk [2]. The practical message is that technique, settings, and aftercare matter as much as skin type. This is one reason resurfacing procedures such as ablative fractional carbon dioxide laser for acne scars are approached carefully in darker skin.

Preventing it

Prevention is more effective than treating established pigment, and it begins before the laser [3]. Published prophylaxis strategies for energy-based devices fall into two groups [3]:

• Before treatment: diligent sun protection to avoid treating tanned skin, and in some cases pretreatment with topical agents such as retinoids, hydroquinone, or alpha hydroxy acids to calm pigment activity [3].
• After treatment: strict photoprotection, plus post-procedure measures such as topical corticosteroids or tranexamic acid to limit inflammation and pigment formation [3].

Device choice and settings are part of prevention. Matching the wavelength and energy to a person's skin type, using conservative settings, and spacing sessions all reduce the inflammatory load [1][2]. In the carbon dioxide laser review, ultra-potent topical corticosteroids and topical fusidic acid applied after treatment reduced PIH, probably by controlling post-procedure inflammation [2]. Because sun exposure is a modifiable driver, daily broad-spectrum protection is a cornerstone; our photoprotection guide covers it in detail. Talking through skin type and realistic settings during a consultation is part of lowering risk, a theme in our guide to energy-based treatment consultations.

Treating it once it appears

When PIH develops, treatment overlaps with the general approach to hyperpigmentation and rewards patience [1]. Evidence-based options include [1][4]:

• Photoprotection, which is foundational because ultraviolet and visible light deepen existing pigment [1].
• Topical lightening agents, including hydroquinone, retinoids, and azelaic acid, which reduce pigment production and speed cell turnover [1][4]. The same triple-combination approach used for melasma is sometimes applied; see our triple-combination cream explainer.
• Chemical peels, used cautiously, which can accelerate clearance but carry their own risk of irritation and further pigment in darker skin [1].
• Tranexamic acid, topical or oral, used as an adjunct to limit pigment; our review of tranexamic acid for pigment covers the evidence and the clotting cautions that make oral use a prescription decision.

Most post-laser PIH improves over weeks to months with consistent topical treatment and sun protection [1][4]. Additional laser treatment is generally avoided while PIH is active, because more inflammation can worsen it [1].

When it is a melasma flare, not simple PIH

Not all darkening after a laser is straightforward PIH. Lasers and light devices can also trigger or worsen melasma, and results for melasma are mixed, with a real risk of rebound within months [5]. Melasma-prone skin that darkens after treatment may be flaring rather than showing simple PIH, and the distinction changes the plan, because melasma is managed long term rather than cleared for good [4][5]. Telling pigment patterns apart matters; our guide to differentiating facial pigmentation walks through the clues, and any new or changing pigmented lesion should be evaluated before further cosmetic treatment.

Adverse events, limitations, and realistic expectations

• Skin of color carries higher risk. PIH is more likely, and can be more stubborn, in Fitzpatrick III to VI skin [3].
• It is usually temporary but slow. Most cases fade over weeks to months; clearance is gradual, not immediate [1][4].
• Prevention beats treatment. Sun protection, appropriate settings, and pretreatment lower risk more reliably than treating established pigment [2][3].
• Treatments can irritate. Topical lighteners and peels can themselves cause irritation and, in darker skin, more pigment if used too aggressively [1].
• Melasma may rebound. When laser is used on melasma-prone skin, darkening can reflect a flare that recurs rather than simple PIH [5].
• Evidence is limited. Reviews note a shortage of large, high-quality trials on preventing and treating device-related PIH [2][3].

Bottom line

Post-laser hyperpigmentation is a common but usually temporary complication of energy-based treatments, driven by inflammation and most likely in richer skin tones [2][3]. Much of the risk is preventable through sun protection, appropriate device settings, and pretreatment, and established pigment usually responds to photoprotection and topical lightening agents over time [1][3][4]. When darkening appears on melasma-prone skin, it may be a flare that needs long-term management rather than simple PIH [5]. Matching the treatment to the skin type, with an experienced provider, is the most dependable way to keep the risk low.

This article is for informational purposes and does not constitute medical advice.